Pharmabiz12h
Cipla’s Breathefree initiative works on empowerment across the care continuum this asthma awareness month in May
Cipla’s Breathefree initiative works on empowerement across the care continuum this asthma awareness month in May. The significance of effective asthma management comes into sharp focus amidst the ...
Pharmabiz13h
Ventus Therapeutics’ partner Novo Nordisk doses first participant in phase 1 study of NNC6022-0001, an oral NLRP3 inhibitor
Ventus Therapeutics’ partner Novo Nordisk doses first participant in phase 1 study of NNC6022-0001, an oral NLRP3 inhibitor: Waltham, Massachusetts Monday, May 6, 2024, 15:00 Hr ...
Pharmabiz10h
Bespak and Medicines Evaluation Unit collaborate to accelerate clinical trials on climate-friendly inhalers
Bespak and Medicines Evaluation Unit collaborate to accelerate clinical trials on climate-friendly inhalers: Holmes Chapel, England Monday, May 6, 2024, 18:00 Hrs [IST] Bespak, a ...
Pharmabiz11h
Bimini Health Tech launches rebranded Puregraft Serene Breast Implants
Bimini Health Tech launches rebranded Puregraft Serene Breast Implants: Plano, Texas Monday, May 6, 2024, 17:00 Hrs [IST] Bimini Health Tech, a global leader in regenerative thera ...
Pharmabiz17h
Bespak, H&T Presspart ink collaboration to advance transition to low GWP propellants in pressurised Metered Dose Inhalers
Bespak, H&T Presspart ink collaboration to advance transition to low GWP propellants in pressurised Metered Dose Inhalers: Holmes Chapel, UK Monday, May 6, 2024, 11:00 Hrs [IST] B ...
Pharmabiz11h
Lupin receives US FDA approval for travoprost ophthalmic solution USP
Lupin receives US FDA approval for travoprost ophthalmic solution USP: Our Bureau, Mumbai Monday, May 6, 2024, 17:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...
Pharmabiz12h
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets
Targeting anti-cancer therapy to affect cancer cells but not healthy cells is challenging. For chimeric antigen receptor (CAR) T–cell immunotherapy, where a patient’s own immune cells are ...
Pharmabiz7h
ACKO launches ambulance-booking feature on app in partnership with Red.Health
ACKO, the tech-first insurer, has added a feature of booking an ambulance on its mobile app. The company said that it aligns with ACKO's vision of becoming a one-stop destination for all protection ...
Pharmabiz19h
Sentynl, a Zydus Group company acquires Zokinvy to treat Hutchinson-Gilford progeria syndrome from Eiger BioPharma
Sentynl, a Zydus Group company acquires Zokinvy to treat Hutchinson-Gilford progeria syndrome from Eiger BioPharma: Our Bureau, Mumbai Monday, May 6, 2024, 09:00 Hrs [IST] Sentynl ...
Pharmabiz15h
New screening trial to save thousands of men’s lives from prostate cancer
New screening trial to save thousands of men’s lives from prostate cancer: United Kingdom Monday, May 6, 2024, 13:00 Hrs [IST] Thousands more men could be saved every year as a ...
Pharmabiz14h
Vesica Health introduces AssureMDx test to improve bladder cancer detection
Vesica Health introduces AssureMDx test to improve bladder cancer detection: Irvine, California Monday, May 6, 2024, 14:00 Hrs [IST] Vesica Health, Inc., a leading multi-omics liq ...
Pharmabiz16h
US FDA announces availability of draft guidance on pharmaceutical development for veterinary drug products
US FDA announces availability of draft guidance on pharmaceutical development for veterinary drug products: Rockville, Maryland Monday, May 6, 2024, 12:00 Hrs [IST] The US Food an ...